Multiple pregnancy rate · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in multiple pregnancy rate compared with placebo/no treatment (low certainty).
1 finding from 1 review
Adverse events, OHSS, preterm delivery, congenital anomaly · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth or ongoing pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in live birth rate/ongoing pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Miscarriage per clinical pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in miscarriage rate per clinical pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Clinical pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone may leads to higher clinical pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Multiple pregnancy · women with oral (clomiphene citrate or letrozole) stimulation
Progesterone showed no clear difference in multiple pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Adverse events, OHSS, preterm delivery, congenital anomaly · women with oral (clomiphene citrate or letrozole) stimulation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth or ongoing pregnancy · women with gonadotropin stimulation
Progesterone showed no clear difference in live birth rate/ongoing pregnancy rate compared with placebo/no treatment (low certainty).
1 finding from 1 review
Miscarriage per clinical pregnancy · women with gonadotropin stimulation
Progesterone showed no clear difference in miscarriage rate per clinical pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Withdrawals due to any reason · women with seizures due to catamenial epilepsy
Progesterone showed no clear difference in number of withdrawals from the study: for any reason compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events: any adverse event · women with seizures due to catamenial epilepsy
Progesterone showed no clear difference in adverse events: any adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Quality of life · women with seizures due to catamenial epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Seizure freedom · women with seizures due to catamenial epilepsy
Progesterone showed no clear difference in seizure freedom: all seizures compared with placebo (low certainty).
1 finding from 1 review
50% or greater reduction in seizure frequency · women with seizures due to catamenial epilepsy
Progesterone showed no clear difference in responder rate: 50% or greater reduction in all seizures compared with placebo (moderate certainty).
1 finding from 1 review
Seizure frequency · women with seizures due to catamenial epilepsy
1 finding from 1 review
Miscarriage · women with threatened miscarriage
Progesterone probably leads to lower miscarriage compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Preterm birth · women with threatened miscarriage
Progesterone showed no clear difference in preterm birth compared with placebo or no treatment (low certainty).
1 finding from 1 review
Congential abnormalities · women with threatened miscarriage
It is very uncertain whether progesterone changes congential abnormalities compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Benzodiazepine discontinuation, end of intervention · adults who withdraw from chronic benzodiazepine use
It is very uncertain whether progesterone changes benzodiazepine discontinuation, end of intervention compared with placebo (very low certainty).
1 finding from 1 review
Benzodiazepine discontinuation, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review